ZTS acquires NVET for $6.72/sh in cash—a 66% premium to yesterday’s close: http://finance.yahoo.com/news/zoetis-acquire-nexvet-biopharma-innovator-132400773.html The nominal deal value is $85M. ZTS is the 2013 animal-health spin-off from PFE (#msg-84067350). p.s. NVET was the answer to a difficult quiz on this board (#msg-118803169).